A disodium phosphonooxymethyl
prodrug of the antitumor agent triptolide
was prepared from the natural product in three steps (39% yield) and
displayed excellent aqueous solubility at pH 7.4 (61 mg/mL) compared
to the natural product (17 μg/mL). The estimated shelf life
(t90) for hydrolysis of the prodrug at
4 °C and pH 7.4 was found to be two years. In a mouse model of
human colon adenocarcinoma (HT-29), the prodrug administered intraperitoneally
was effective in reducing or eliminating xenograft tumors at dose
levels as low as 0.3 mg/kg when given daily and at 0.9 mg/kg when
given less frequently. When given via intraperitoneal and oral routes
at daily doses of 0.6 and 0.9 mg/kg, the prodrug was also effective
and well tolerated in a mouse model of human ovarian cancer (A2780).